Hyperforin modulation of drug resistance: saint or sinner?
Rund
Deborah
D
Hematology Department, Hadassah University Hospital, Jerusalem, Israel 91120. rund@cc.huji.ac.il
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D000070997:ATP Binding Cassette Transporter, Subfamily G, Member 2; D018528:ATP-Binding Cassette Transporters / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology; D018432:Drug Resistance, Multiple; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D022423:Myeloid Cells / Q000187:drug effects; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D010696:Phloroglucinol / Q000031:analogs & derivatives* / Q000494:pharmacology; D013729:Terpenes / Q000494:pharmacology*
C116614:ABCG2 protein, human; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000070997:ATP Binding Cassette Transporter, Subfamily G, Member 2; D018528:ATP-Binding Cassette Transporters; D001643:Bridged Bicyclo Compounds; D009363:Neoplasm Proteins; D013729:Terpenes; D010696:Phloroglucinol; C001654:hyperforin